Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
about
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cellsThe regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genesResistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacinIn vivo antibiotic synergism: contribution of animal models.Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications.Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistanceAntibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.Resistance to pefloxacin in Pseudomonas aeruginosa.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Pseudomonas skin infection: clinical features, epidemiology, and management.Quinolone antimicrobial agents: adverse effects and bacterial resistance.The 4-quinolone antibiotics: past, present, and future.Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.Autogenous fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion: morbidity, mortality and microbiological response.Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance.Assessment of the potential for microbial resistance to topical use of multiple antimicrobial agents.In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
P2860
Q24676018-C8454134-9490-43FD-8B9F-57FBFE78E9DDQ28493156-5680CCD7-4D80-4AB8-AEBD-347E1DCECFEFQ33742745-F949E111-A431-43FA-83E9-64E11AE6D6E0Q33982098-E779223E-B99E-489E-9BC2-742702F19928Q33982298-8B5A60E8-8FC0-49DE-8E23-7957F829E1FDQ35243870-332C9B8C-6383-42DC-AC8D-9E0DBF350E97Q35754023-859B60CB-04EC-48AF-A2C6-AAA98E0347CFQ35818681-451006E5-6620-44B5-8C0A-BD3C7AA9CB63Q35836280-3A13F7C3-F05E-4861-8666-2BCF683006ECQ36031279-0A15F255-BA22-456A-84B2-9DF4A889D3ECQ36123973-686B5496-0C8E-46FC-936B-E7668838EC7BQ36528206-422D2FE9-9DAB-4F5F-B96E-0C4EA801DA59Q36593833-2756D6F2-C9CB-4577-B791-4F49081BA782Q36753117-AE1EF64A-4ADB-4696-87F5-74B1D00B4DDBQ36863646-45264B4F-1B8C-4AFC-B29C-1CCA6C41FC4BQ37862227-840E5DA0-8201-4002-AD87-06982A1378B3Q38322827-377F2A56-46AB-4460-BF1E-B6EEDB947AFCQ39314610-E2946F24-697B-4C93-B94C-6D228A37AA5BQ39783997-3D5265BB-6303-4256-BF94-CF43A7C8680BQ39816779-570491FE-2A58-4269-AE6F-FE05F12529C0Q39817132-3C11ADB8-63D4-4A3A-9170-12E54F23EE99Q40284449-272B5C1B-0CA3-4DDF-A45B-69FDD215B2BDQ40633555-68F56F96-A031-4306-AD6F-7711AF454EDFQ44092862-4DC5DF6D-C6AA-4552-A810-2D46F116BD72Q46353499-05807CB8-DD97-4B46-A0E2-0C22E639F9FDQ53846362-D5FF052B-0224-4513-A121-C52AFEB5504BQ54221210-E55484B6-5992-4CA9-8276-71C20FC8F7F6Q54302894-E455CB69-1181-4128-BDC7-88DDD27BF0F7
P2860
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@ast
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@en
type
label
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@ast
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@en
prefLabel
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@ast
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@en
P2093
P2860
P356
P1476
Resistance occurring after flu ...... omonas aeruginosa peritonitis.
@en
P2093
Auckenthaler R
Michéa-Hamzehpour M
Pechère JC
P2860
P304
P356
10.1128/AAC.31.11.1803
P407
P577
1987-11-01T00:00:00Z